Our findings support a functional difference between IRP1 and IRP2 by demonstrating that IRP2 is specifically co-opted by prostate cancer cells to alter normal iron homeostasis and retain increased intracellular iron (Figure 2). This evidence concerns the gene ACO1 and prostate carcinoma.